- Home
- TNGX vs ILLR Comparison
TNGX vs ILLR Comparison
Compare TNGX & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ILLR
- Stock Information
- Founded
- TNGX 2014
- ILLR 2015
- Country
- TNGX United States
- ILLR United States
- Employees
- TNGX N/A
- ILLR N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ILLR Investment Managers
- Sector
- TNGX Health Care
- ILLR Finance
- Exchange
- TNGX Nasdaq
- ILLR Nasdaq
- Market Cap
- TNGX 317.4M
- ILLR 304.1M
- IPO Year
- TNGX N/A
- ILLR N/A
- Fundamental
- Price
- TNGX $1.76
- ILLR $0.79
- Analyst Decision
- TNGX Strong Buy
- ILLR
- Analyst Count
- TNGX 7
- ILLR 0
- Target Price
- TNGX $12.33
- ILLR N/A
- AVG Volume (30 Days)
- TNGX 801.9K
- ILLR 567.6K
- Earning Date
- TNGX 05-07-2025
- ILLR 03-25-2025
- Dividend Yield
- TNGX N/A
- ILLR N/A
- EPS Growth
- TNGX N/A
- ILLR N/A
- EPS
- TNGX N/A
- ILLR N/A
- Revenue
- TNGX $42,069,000.00
- ILLR $45,244,000.00
- Revenue This Year
- TNGX N/A
- ILLR N/A
- Revenue Next Year
- TNGX N/A
- ILLR N/A
- P/E Ratio
- TNGX N/A
- ILLR N/A
- Revenue Growth
- TNGX 15.17
- ILLR N/A
- 52 Week Low
- TNGX $1.71
- ILLR $0.66
- 52 Week High
- TNGX $12.02
- ILLR $8.86
- Technical
- Relative Strength Index (RSI)
- TNGX 33.97
- ILLR N/A
- Support Level
- TNGX $1.80
- ILLR N/A
- Resistance Level
- TNGX $2.04
- ILLR N/A
- Average True Range (ATR)
- TNGX 0.18
- ILLR 0.00
- MACD
- TNGX 0.01
- ILLR 0.00
- Stochastic Oscillator
- TNGX 20.19
- ILLR 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.